Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
iBio, Inc., a company working on plant-based biotechnology for developing and manufacturing biological products, has announced the formation of a joint venture with affiliates of Eastern Capital Limited to develop and manufacture plant-made ...
read more
iBio introduced new cGMP sterile fill-finish capabilities for pharmaceutical products, including monoclonal antibodies, viral vectors, and other biologics.
read more
Thursday, August 29, 2019
iBio has entered into a Master Services Agreement with Lung Biotechnology PBC to produce recombinant human collagen-based bioink for 3D bioprinted organ transplants.
read more
Tuesday, January 10, 2017
Drug discovery services and products provider Icagen, Inc. has announced an agreement with Japan-based drug discovery sales specialist On Target Co., Ltd. granting On Target Company, Ltd. rights to broker Icagen's products and services in this ...
read more
Icagen, Inc. announced that Dr. Chris Mathes has been appointed Chief Commercial Officer to help drive Icagen's expanding drug discovery and ion channel services business.
read more
Icagen, Inc. announced today that the acquisition of Sanofi's ultra high-throughput biology, screening and chemistry capabilities and research facility in Oro Valley, Arizona (located nearTucson, Arizona) is officially complete.
read more
Icagen, Inc., a provider of services and expertise for ion channel and transporter drug discovery and development, has announced that the company is consolidating its research operations and relocating corporate headquarters to its facility in the ...
read more
Wednesday, December 05, 2018
Icagen has entered into a license and collaboration agreement with Roche to develop and commercialize small molecule ion channel modulators for the treatment of neurological disorders.
read more
iCardiac Technologies, a provider of cardiac safety assessment services to the pharmaceutical industry, has added respiratory and ePRO services to its suite of offerings through the acquisition of the clinical trials division of nSpire Health.
read more
iCardiac Technologies, Inc., a scientific leader in the conduct of cardiac safety assessments, today announced it is providing industry-wide access to its pivotal dataset as part of an effort announced by the Cardiac Safety Research Consortium to ...
read more
The ICDD and the CCDC have announced a new partnership, which will allow greater utility and insights in the development of new drugs and materials.
read more
Tuesday, September 03, 2019
IceCure Medical has announced an exclusive distribution agreement with global medical company, Terumo Corporation.
read more
Tuesday, November 26, 2019
ValGenesis has announced an Iceland-based biotech firm has selected ValGenesis's VLMS as their platform for validation process management across multiple sites.
read more
Monday, November 20, 2023
Ichor Life Sciences, a comprehensive contract research organization (CRO), has introduced Ichor Clinical Trial Services, expanding its capabilities to cater to the needs of biotechnology and pharmaceutical clients throughout the entire drug ...
read more
Tuesday, December 21, 2021
Ichor Life Sciences, a preclinical contract research organization offering services in discovery through pharmacology, has formally completed the acquisition of Woodland Biosciences, Inc. The in vivo services for the study of metabolic diseases and ...
read more